Though things are looking up for Akero, the stock still looks risky. Akero Therapeutics is developing efruxifermin as a ...

Netflix ( NFLX 0.36%) has shown investors once again who's on top of the streaming industry. On Jan. 21, the company reported ...

On Jan. 27, Nvidia ( NVDA -3.67%) fell 17%, erasing over $590 billion from its market cap. It marked the greatest single-day ...

The stock market's climb over the last few years has driven dividend yields to multiyear lows. The S&P 500 average yield is ...

Although DeepSeek gave investors a scare when its R1 model impressed everyone with its performance at its price point, it's becoming clearer that this breakthrough wasn't a death blow to the domestic ...

Credit card debt can be especially difficult in retirement because of its high interest rates. Balance transfer cards and ...

Spending on artificial intelligence (AI) has been heating up recently, and it may not necessarily be slowing down. The ...

The last time Nvidia's forward P/E hovered around 30 was last January. This is important to note because back in January 2024, Nvidia's market cap was $1.5 trillion -- approximately half of what it is ...

Nvidia stock saw a massive pullback in Monday's trading, closing out the daily session down 17%. The sell-off worked out to a roughly $600 billion pullback in the GPU leader's market capitalization ...

Thanks to this ongoing momentum, 2025 may be another good one for the Dow Jones, and three stocks in particular might lead ...

The healthcare leader is also an excellent income stock. Johnson & Johnson has increased its dividend payout for 62 consecutive years, making it a Dividend King. Between Johnson & Johnson's strong ...

The result of these and other breakthroughs isn't just an AI model that's faster to train and costs less. The longer-term ...